Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftJN : Journal of Nephrology
Volym29
Utgåva3
Sidor (från-till)359-365
Antal sidor7
ISSN1121-8428
DOI
StatusPublicerad - jun 2016
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3122 Cancersjukdomar

Citera det här

@article{3942fdfcd1c64f4ca66fb15b174e7aae,
title = "Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis",
keywords = "Experimental glomerulonephritis, Epidermal growth factor, Erlotinib, ANGIOTENSIN-II, GLOMERULAR INJURY, IGA NEPHROPATHY, RENAL-FAILURE, KIDNEY, CELL, RAT, LESIONS, CANCER, 3122 Cancers",
author = "Rintala, {Jukka M.} and Johanna Savikko and Rintala, {Sini E.} and Niina Palin and Koskinen, {Petri K.}",
year = "2016",
month = "6",
doi = "10.1007/s40620-015-0233-x",
language = "English",
volume = "29",
pages = "359--365",
journal = "JN : Journal of Nephrology",
issn = "1121-8428",
publisher = "WICHTIG EDITORE S.R.L",
number = "3",

}

TY - JOUR

T1 - Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis

AU - Rintala, Jukka M.

AU - Savikko, Johanna

AU - Rintala, Sini E.

AU - Palin, Niina

AU - Koskinen, Petri K.

PY - 2016/6

Y1 - 2016/6

KW - Experimental glomerulonephritis

KW - Epidermal growth factor

KW - Erlotinib

KW - ANGIOTENSIN-II

KW - GLOMERULAR INJURY

KW - IGA NEPHROPATHY

KW - RENAL-FAILURE

KW - KIDNEY

KW - CELL

KW - RAT

KW - LESIONS

KW - CANCER

KW - 3122 Cancers

U2 - 10.1007/s40620-015-0233-x

DO - 10.1007/s40620-015-0233-x

M3 - Article

VL - 29

SP - 359

EP - 365

JO - JN : Journal of Nephrology

JF - JN : Journal of Nephrology

SN - 1121-8428

IS - 3

ER -